The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions.
We’ll bring together 600+ key thought leaders to explore these challenges within pharmacovigilance.
Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally.
Patient groups, Regulators, Pharmaceutical Associations, Not- for- Profit’s and any other governmental agencies/ organisations can apply for a Regulatory Bursary.
World Drug Safety Europe 2020 offers outstanding opportunities for solutions providers, from senior sponsorship to a range of exhibition booths on a large floor plan.